myirislogo
04 March, 2015 14:01 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 301.10 0.55
I T C 350.35 2.64
Axis Bank 628.30 0.72
Icici Bank 357.30 2.55
Sun Pharma 1024.50 8.71
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:532872NSE:SPARCBloomberg:SPADV@INReuters:SPRC.BO
Market Lot: 1Face Value: 1ISIN Demat: INE232I01014
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
04-MAR-15 Sun Pharma Advanced Research Company (SPARC) today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for ELEPSIA XR (Levetiracetam extended-release tablets 1000 mg and 1500 mg). ELE PSIA XR is indicated for adjunctive therapy in the treatment of partial onset seizures in patients 12 years of age and older with epilepsy. 02-DEC-14 Sun Pharma Advanced Research ,(SPARC), is pharma re...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Sun Pharma gets USFDA nod for ELEPSIA XR   -IRIS 04-Mar-15
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2014(9)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1130.401670.30872.80
Other Income30.30100.0016.20
Total Income1160.701770.30889.00
Cost of goods sold1405.601335.401040.40
OPBDIT-244.90434.90-151.40
PAT-301.20303.20-224.90
Gross Block---
Equity capital236.70236.70236.60
EPS (Rs.)-1.28-1.03
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-82.19 - 140.23NA
Debt / Equity (x)---
Operating margin (% of OI)-21.124.6-17.0
Net margin (% of OI)-25.917.1-25.3
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Sun Pharma Advanced Research Centre
Akota Road
Akota
Vadodara
Gujarat-390 020
PHONE
(0265) 2330 815
FAX
(0265) 2354 897
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer